BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6162182)

  • 1. [The effect of mepartricin on prostatic adenoma].
    Pellet B; Granata F; von Niederhäusern W
    Rev Med Suisse Romande; 1980 Nov; 100(11):899-903. PubMed ID: 6162182
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of mepartricin in the medical treatment of benign prostatic adenoma].
    Casella G; Barbaro A
    Arch Sci Med (Torino); 1978; 135(1):95-8. PubMed ID: 76466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of the use of mepartricin in the therapy of prostatic hypertrophy. Double-blind study].
    Cortecchia V; Scarano P; D'Amato G; Soli M; Rusconi R; Buli P
    Minerva Urol Nefrol; 1988; 40(2 Suppl):44-6. PubMed ID: 2460949
    [No Abstract]   [Full Text] [Related]  

  • 4. [Double-blind study on the effects of mepartricin (SPA-S-160) versus placebo in the treatment of obstruction caused by adenoma of the prostate].
    Rizzo M; Tosto A; Dattolo E; Serni S
    Minerva Urol Nefrol; 1988; 40(2 Suppl):21-2. PubMed ID: 2460940
    [No Abstract]   [Full Text] [Related]  

  • 5. [Randomized double-blind study using mepartricin and a placebo in the therapy of benign prostatic hypertrophy].
    Miano L; Manieri C; Paradiso Galatioto G
    Minerva Urol Nefrol; 1988; 40(2 Suppl):50-2. PubMed ID: 2460952
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic efficacy of mepartricin in the medical treatment of prostatic hypertrophy].
    Virgili G; Mearini E; Sbarberi L; Camilli P; Costantini E
    Minerva Med; 1986 May; 77(20):861-6. PubMed ID: 2425285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the pharmacological effect of mepartricin in urological pathology by prostatic superficial echotomography].
    Gasparini-Casari M; Palmieri B; Noera G; Ferrari P
    Minerva Urol; 1980; 32(1):5-10. PubMed ID: 6155599
    [No Abstract]   [Full Text] [Related]  

  • 8. [Latest contribution concerning the use of mepartricin in adenoma of the prostate].
    Comar OB; Di Rienzo A
    Minerva Urol Nefrol; 1988; 40(2 Suppl):30-2. PubMed ID: 2460944
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic usefulness of mepartricin in benign prostatic hypertrophy: 2 years' experience. Preliminary note on the effect of mepartricin on certain possible etiopathogenic factors in benign prostatic hypertrophy].
    Mirone V; Prezioso D; Palmieri A; Bocchini P
    Minerva Urol Nefrol; 1988; 40(2 Suppl):16-7. PubMed ID: 2460938
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of mepartricin in benign prostatic hypertrophy].
    Giannotti P; Murzi P; Marconi A; Pistolesi D; Morelli G
    Minerva Urol Nefrol; 1988; 40(3):175-80. PubMed ID: 2467388
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of the results and tolerance of prolonged treatment with mepartricin].
    Bianchi G; Curti P; De Iorio M; Mobilio G
    Minerva Urol Nefrol; 1988; 40(2 Suppl):33-4. PubMed ID: 2460945
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experience with mepartricin in the treatment of prostatic hypertrophy. Preliminary results].
    Bassi P; Oliva G; Tasca A; Aragona F; Milani C; Zattoni F
    Minerva Urol Nefrol; 1988; 40(2 Suppl):40-3. PubMed ID: 2460948
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of the objective efficacy of mepartricin in benign prostatic hypertrophy].
    Cirillo Marucco E; Giocoli Nacci G; Pagliarulo A; Balacco G; Ludovico G
    Minerva Urol Nefrol; 1988; 40(2 Suppl):23-4. PubMed ID: 2460941
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mepartricin versus placebo in the therapy of prostatic hypertrophy].
    Fini M; Perrone A; Ferraresi R; Salvi G; Misuriello G; Vagliani GF
    Minerva Urol Nefrol; 1988; 40(2 Suppl):53-4. PubMed ID: 2460953
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical and echographic evaluation of a group of 40 patients suffering from benign prostatic hypertrophy treated with mepartricin].
    Alei G
    Minerva Urol Nefrol; 1988; 40(2 Suppl):59-61. PubMed ID: 2460955
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mepartricin in the treatment of benign prostatic hyperplasia].
    Cirillo Marucco E; Pagliarulo A; Piccinno A; Di Rienzo U
    Minerva Urol Nefrol; 1988; 40(2):101-4. PubMed ID: 2459784
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prolonged medical therapy using mepartricin in prostatic hypertrophy. Results in 81 patients].
    Serretta V; Pavone C; Di Trapani D; Romano C; Costa G; Caramia G
    Minerva Urol Nefrol; 1988; 40(2 Suppl):55-8. PubMed ID: 2460954
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of mepartricin in the treatment of benign prostatic hypertrophy. Open study of 39 patients].
    Montanari E; Patelli E; Mandressi A; Magri V; Pisani E
    Minerva Urol Nefrol; 1988; 40(2 Suppl):25-9. PubMed ID: 2460942
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of mepartricin in the patient suffering from so-called benign prostatic hypertrophy. Study of 142 cases].
    Fiorilla C
    Minerva Urol Nefrol; 1988; 40(2 Suppl):35-7. PubMed ID: 2460946
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mepartricin in prostatic hypertrophy. Results in 20 cases].
    Durval A; Rovereto B; Tosto A; Paoletti MC; Natali A; Pellegrini GL
    Minerva Urol Nefrol; 1986; 38(1):81-5. PubMed ID: 2426804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.